Forward Citations = 101

Loading Chart...

12 inventors (with patents filed for the assignee):

Mircea C Popescu (3 out of 24 patents)

Lawrence T Boni (2 out of 17 patents)

Michael M Batenjany (2 out of 2 patents)

4. Augusto C Ochoa (2 out of 14 patents)

5. Richard J Robb (2 out of 2 patents)

6. Stella Gevantmakher (1 out of 1 patent)

7. Larry Kwak (1 out of 1 patent)

8. Larry Boni (1 out of 1 patent)

9. Dan L Longo (1 out of 13 patents)

10. Paritosh Ghosh (1 out of 4 patents)

11. Howard A Young (1 out of 4 patents)

12. Mary Neville (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6544549 - Multilamellar coalescence vesicles (MLCV) containing biologically active compounds (2003-04-08),

2. 6312718 - Vaccine for B-cell malignancies (2001-11-06),

3. 6207170 - Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes (2001-03-27),

4. 5658744 - Methods of identifying patients having an altered immune status (1997-08-19),

Company Overview

Biomira USA Inc. is a leading biotechnology company focused on the development and commercialization of innovative cancer immunotherapies. With a strong commitment to research and development, Biomira USA Inc. aims to improve the treatment options available to cancer patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#25 in Cranbury, NJ

#2,205 in New Jersey

#60,671 in US

Cranbury, NJ, United States of America

Biomira USA Inc.

Forward Citations = 101

12 inventors:

Mircea C Popescu (3 out of 24 patents)

Lawrence T Boni (2 out of 17 patents)

Michael M Batenjany (2 out of 2 patents)

4. Augusto C Ochoa (2 out of 14 patents)

5. Richard J Robb (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biomira USA Inc.. Retrieved from https://idiyas.com/company/biomira-usa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]